Literature DB >> 1691297

Alphafetoprotein in midtrimester Down's syndrome fetal serum.

M J Seller1.   

Abstract

Serum alphafetoprotein was estimated in fetuses with and without Down's syndrome or with other chromosome abnormalities from the 17th to the 28th week of pregnancy. In normal fetuses, the AFP level declines steadily during this period. Before 20 weeks, there was no difference in the serum AFP levels of the three groups of fetuses. After 20 weeks, the serum AFP level in cases of Down's syndrome declined more rapidly than normal. This was not observed in fetuses with other chromosome abnormalities. This suggests that low maternal serum alphafetoprotein levels used for prenatal screening for Down's syndrome in the early second trimester cannot be explained by low levels in the Down's fetuses themselves.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691297      PMCID: PMC1017025          DOI: 10.1136/jmg.27.4.240

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  Low alpha-fetoprotein and serum albumin levels in Morbus Down may point to a common regulatory mechanism.

Authors:  T Voigtländer; F Vogel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Cord serum alpha-fetoprotein and Down's syndrome.

Authors:  H S Cuckle; N J Wald; R H Lindenbaum
Journal:  Br J Obstet Gynaecol       Date:  1986-04

3.  Weights of fetuses with autosomal trisomies at termination of pregnancy: an investigation of the etiologic factors of low serum alpha-fetoprotein values.

Authors:  C L Librach; C K Hogdall; T A Doran
Journal:  Am J Obstet Gynecol       Date:  1988-02       Impact factor: 8.661

4.  The effects of chromosome abnormalities on birth weight in man. II. Autosomal defects.

Authors:  A T Chen; Y K Chan; A Falek
Journal:  Hum Hered       Date:  1972       Impact factor: 0.444

5.  Low maternal serum AFP and Down syndrome.

Authors: 
Journal:  Lancet       Date:  1984-07-21       Impact factor: 79.321

6.  Maternal serum-AFP as screening test for Down syndrome.

Authors:  W Fuhrmann; P Wendt; H K Weitzel
Journal:  Lancet       Date:  1984-08-18       Impact factor: 79.321

7.  Prenatal screening for Down syndrome.

Authors: 
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

8.  Levels of albumin, alpha-fetoprotein, and IgG in human fetal cerebrospinal fluid.

Authors:  M Seller MJadinolfi
Journal:  Arch Dis Child       Date:  1975-06       Impact factor: 3.791

9.  An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.

Authors:  I R Merkatz; H M Nitowsky; J N Macri; W E Johnson
Journal:  Am J Obstet Gynecol       Date:  1984-04-01       Impact factor: 8.661

10.  Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome.

Authors:  H S Cuckle; N J Wald; R H Lindenbaum
Journal:  Lancet       Date:  1984-04-28       Impact factor: 79.321

View more
  1 in total

1.  A comparative analysis of synonymous codon usage bias pattern in human albumin superfamily.

Authors:  Hoda Mirsafian; Adiratna Mat Ripen; Aarti Singh; Phaik Hwan Teo; Amir Feisal Merican; Saharuddin Bin Mohamad
Journal:  ScientificWorldJournal       Date:  2014-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.